Skip to main content
  1. Home
  2. Emerging Tech
  3. Photo Galleries
  4. News

Google’s latest crazy idea? Uber-cheap wind turbines that fly like kites

Add as a preferred source on Google

At any given moment, Google X (the search giant’s experimental wing dedicated to making major technological advances) has a boatload of lofty, ambitious, and downright ridiculous ideas in the works. Many of these never see the light of day, but next month, one of the company’s more intriguing projects is set to take flight — literally.

Starting in April, Google plans to start testing a fleet of 84-foot wind turbines –But these aren’t your average wind turbines. Designed by California wind energy company Makani Power, these turbines don’t have towers. Instead, they’re designed to float in the air like kites.

Makani Airborne Wind Turbine

Basically, these lightweight, carbon-fiber kites (which look more like airplanes) are sent into the air while tethered to a docking station on the ground. Once released, they raise up to an altitude of about 450 meters, or around 1,500 feet, and start making large circles in the sky. This motion turns the plane’s propellors, which spin internal turbines to generate power. All this juice is then sent back down to Earth through the tether.

Why collect power in this fashion? Well for starters, winds are typically stronger at higher altitudes. Flying up to 1,500 feet allows the energy kites to capture as much as 50 percent more power than ground-level turbines. On top of that, Makani’s kites require drastically fewer resources to produce/construct, so they can be deployed faster and more easily. In a nutshell, they can generate more power at a lower cost.

The system definitely isn’t without it’s flaws, but it’s exciting to see Google bringing it out of the lab and really starting to move the technology forward.

Drew Prindle
Former Senior Editor, Features
Drew Prindle is an award-winning writer, editor, and storyteller who currently serves as Senior Features Editor for Digital…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more